Beware of fraudulent job postings claiming to represent our company. Verify all job listings on our official website, never pay for job applications or interviews, and avoid downloading software to secure an interview. Your security is our priority.
By Frank DiamondAug 14, 2023
CareFirst BlueCross BlueShield is joining forces with Ryse Health, a company that specializes in providing in-person and virtual care for patients with uncontrolled Type 2 diabetes, in hopes of driving better long-term outcomes.
CareFirst officials said they believe the effort will help improve care by better pinpointing what they need most.
Aug 8, 2023 | 1501 Health
Chronic disease, cardiometabolic health in particular, is a massive problem in the United States—significantly impacting many lives in a negative way, leading to millions of deaths every year and costing nearly a trillion dollars.
It's clear there's an approach that could deliver better outcomes than the status quo of care, and Ryse Health, based in Maryland and DC and led by Richard Gurley, is providing it.
Erin Brodwin , author of Axios Pro: Health Tech Deals
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Published May 24, 2022
When I was leaving WelbeHealth, I was intent on being thoughtful about my next full-time role. I told my wife, “I don’t know if I’ll end up at a 4-person company or a 40,000-person company, but the one thing I know I won’t do is start my own company.” And yet, here I am: co-founder of Ryse Health, a new startup helping patients manage type 2 diabetes and other chronic diseases. The obvious question that springs from that epic flip flop is “Why?”
Apr 11, 2022 4:10pm
Cofounder and Chief Medical Officer Dr. Erin Kane says that the Baltimore- and DMV-rooted startup wants to expand its clinical and technological capacity as it grows into new markets.